Meeting Program

To view program in "24 hour" time (international) click here.

Saturday, February 12
3:00 - 7:30 PM	Registration	Sweeney Ballroom Foyer
6:30 - 7:30 PM	Refreshments	Sweeney Ballroom A-B
7:30 - 9:30 PM	Keynote Session (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom C-F
	Michael Karin, University of California, San Diego, USA Inflammation, Immunity and Cancer
	Jean-Laurent Casanova, Rockefeller University, USA A Genetic Dissection of Immunity to Infection in Natura
Sunday, February 13
7:00 - 8:00 AM	Breakfast	Sweeney Ballroom A-B, Main Level Breakout Rooms
8:00 - 11:00 AM	Origins of Dendritic Cells Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom F
	Michel C. Nussenzweig, Rockefeller University, USA Title to be Determined
	Boris Reizis, Columbia University, USA Plasmacytoid Dendritic Cell Development
	Steffen Jung, Weizmann Institute of Science, Israel Origins and Functions of Mononuclear Phagocytes
	Miriam Merad, Mount Sinai Medical Center, USA Regulation of Development and Function of Non-Lymphoid Tissue Dendritic Cells
	Short Talk(s) to be Chosen from Abstracts,
Following Session is for Tumor Immunology (J8)
8:00 - 11:00 AM	Pathogenesis: Cancer and Inflammation Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom C-E
	Wolf-Herman Fridman, Hôpital Européen Georges-Pompidou, France Prognostic of Tumor-Invading Immune Effectors or Regulators in Various Human Malignancies
	Robert D. Schreiber, Washington University School of Medicine, USA Molecular Mechanisms Underlying Cancer Immunoediting
	Giorgio Trinchieri, National Cancer Institute at Frederick, USA Innate Resistance and Inflammation in Cancer
	Laurence Zitvogel, Institut Gustave Roussy, France Unraveling the Key-Lock Paradigm of the Immunogenicity of Cell Death
9:20 - 9:40 AM	Coffee Break	Sweeney Ballroom A-B
11:15 AM- 1:00 PM	Poster Setup	Sweeney Ballroom A-B, Main Level Breakout Rooms
1:00 - 10:00 PM	Poster Viewing	Sweeney Ballroom A-B, Main Level Breakout Rooms
2:30 - 4:30 PM	Workshop 1: A DC by Any Other Name would Still Smell as Sweet	Sweeney Ballroom F
	* Ken Shortman, Walter and Eliza Hall Institute of Medical Research, Australia
	* Gwendalyn J. Randolph, Mount Sinai School of Medicine, USA
	Short Talks to be Chosen from Abstracts, ,
Following Workshop is for Tumor Immunology (J8)
2:30 - 4:30 PM	Workshop 1: Role of IL-17 in Cancer Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom C-E
	Chen Dong, MD Anderson Cancer Center, USA Regulation and Function of IL-17 Family Cytokines
	Short Talks to be Chosen from Abstracts, ,
4:30 - 5:00 PM	Coffee Available	Sweeney Ballroom A-B
5:00 - 7:00 PM	Mechanisms of Antigen Processing by Dendritic Cells Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom F
	Ira Mellman, Genentech, Inc., USA MHC Class II Pathways
	Hidde L. Ploegh, Whitehead Institute for Biomedical Research, USA Title to be Determined
	Sebastian Amigorena, Institut Curie, France Antigen Cross Presentation in DCs
	Christian Münz, University of Zurich, Switzerland Short Talk: Macroautophagy in Antigen Processing for MHC Presentation
	Pierre Guermonprez, Rockfeller University, USA Short Talk
Following Session is for Tumor Immunology (J8)
5:00 - 7:00 PM	Innate Immunity against Cancer Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom C-E
	Eric Vivier, Centre d'Immunologie de Marseille-Luminy, France Unraveling NKp30 Ligands in Cancer
	Veronika Groh-Spies, Fred Hutchinson Cancer Research Center, USA The Flavors of NKG2D in Cancer: Immunosuppresssion or Activation
	Mark J. Smyth, Peter MacCallum Cancer Centre, Australia NKT-Based Immunosurveillance and Antitumor Therapy
	Short Talk to be Chosen from Abstracts,
7:00 - 8:00 PM	Social Hour w/ Lite Bites	Sweeney Ballroom A-B, Main Level Breakout Rooms
7:30 - 10:00 PM	Poster Session 1 Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom A-B, Main Level Breakout Rooms
Monday, February 14
7:00 - 8:00 AM	Breakfast	Sweeney Ballroom A-B, Main Level Breakout Rooms
8:00 - 11:00 AM	Harnessing the Cell Biology of Dendritic Cells against Cancer (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom C-F
	Jacques F. Banchereau, Baylor Institute for Immunology Research, USA Human DC Subsets in Cancer
	Yong-Jun Liu, University of Texas MD Anderson Cancer Center, USA Plasmacytoid DC in Cancer
	Caetano Reis e Sousa, Cancer Research UK, London Research Institute, UK Targeting DC Receptors to Bridge Innate and Adaptive Immunity
	Madhav V. Dhodapkar, Yale School of Medicine, USA Dual Face of DCs in Cancer
	Short Talks to be Chosen from Abstracts, ,
9:20 - 9:40 AM	Coffee Break	Sweeney Ballroom A-B
11:00 AM- 1:00 PM	Poster Setup	Sweeney Ballroom A-B, Main Level Breakout Rooms
1:00 - 10:00 PM	Poster Viewing	Sweeney Ballroom A-B, Main Level Breakout Rooms
2:30 - 4:30 PM	Workshop 2: Antigen Processing and Presentation	Sweeney Ballroom F
	* Jose A. Villadangos, Walter and Eliza Hall Institute, Australia
	* Philippe D. Pierre, Centre National de la Recherche Scientifique, France
	Short Talks to be Chosen from Abstracts, ,
Following Workshop is for Tumor Immunology (J8)
2:30 - 4:30 PM	Workshop 2: Immune Status Response at Different Stages of Tumor Development and Progression Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom C-E
	Short Talks to be Chosen from Abstracts, ,
4:30 - 5:00 PM	Coffee Available	Sweeney Ballroom A-B
5:00 - 7:00 PM	Mechanisms and Consequences of Antigen Presentation by Dendritic Cells Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom F
	Gillian Griffiths, Cambridge Institute for Medical Research, UK The Immunological Synapse, Cilia and Disease
	Frederic Geissmann, Kings College London, UK Talk Title to be Determined
	Bali Pulendran, Emory University, USA Talk Title to be Determined
	Short Talk to be Chosen from Abstracts,
Following Session is for Tumor Immunology (J8)
5:00 - 7:00 PM	Adaptive Immunity against Cancer? Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom C-E
	Richard A. Flavell, Yale University School of Medicine, USA Dysregulation of T Cell Homeostasis during Cancer
	Glenn Dranoff, Dana-Farber Cancer Institute, USA Mechanisms of Protective Tumor Immunity
	Nicholas P. Restifo, National Cancer Institute, National Institutes of Health, USA Re-Imagining the Ideal Antitumor T Cell
	Short Talk to be Chosen from Abstracts,
7:00 - 8:00 PM	Social Hour w/ Lite Bites	Sweeney Ballroom A-B, Main Level Breakout Rooms
7:30 - 10:00 PM	Poster Session 2 Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom A-B, Main Level Breakout Rooms
Tuesday, February 15
7:00 - 8:00 AM	Breakfast	Sweeney Ballroom A-B, Main Level Breakout Rooms
8:00 - 11:00 AM	Dendritic Cells in Tolerance, Inflammation and Autoimmunity Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom F
	Virginia Pascual, Baylor Institute for Immunology Research, USA Neutrophil-Induced pDC Activation in SLE
	Fiona M. Powrie, University of Oxford, UK IBD
	Federica Sallusto, Institute for Research in Biomedicine, Switzerland Talk Title to be Determined
	Julie Magarian Blander, Mount Sinai School of Medicine, USA Infection and Apoptosis as a Combined Inflammatory Trigger
	Short Talk(s) to be Chosen from Abstracts,
Following Session is for Tumor Immunology (J8)
8:00 - 11:00 AM	Clearance of Dying Cells Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom C-E
	Kodi S. Ravichandran, University of Virginia, USA Signaling to Engulfment: The Beginnings of a Good Meal
	Shigekazu Nagata, Kyoto University, Japan Talk Title to be Determined
	Douglas R. Green, St. Jude Children's Research Hospital, USA Talk Title to be Determined
9:20 - 9:40 AM	Coffee Break	Sweeney Ballroom A-B
11:00 AM- 1:00 PM	Poster Setup	Sweeney Ballroom A-B, Main Level Breakout Rooms
1:00 - 10:00 PM	Poster Viewing	Sweeney Ballroom A-B, Main Level Breakout Rooms
4:30 - 5:00 PM	Coffee Available	Sweeney Ballroom A-B
5:00 - 7:00 PM	Sensing Innate Signals by Dendritic Cells and Other Cells Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom F
	Tadatsugu Taniguchi, University of Tokyo, Japan IRFs and Signaling Cross-Talks in the Regulation of Innate Immune Responses
	Shizuo Akira, Osaka University, Japan TLRs
	Jürg Tschopp, University of Lausanne, Switzerland Inflammasome
	Short Talk to be Chosen from Abstracts,
Following Session is for Tumor Immunology (J8)
5:00 - 7:00 PM	Immunosuppressive Components Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom C-E
	Drew M. Pardoll, Johns Hopkins University School of Medicine, USA STAT3, Th17 and Cancer Progression
	Mario P. Colombo, Fondazione IRCCS Istituto Nazionale Tumori, Italy Matricellular Proteins at the Crossroad of Inflammation and Cancer
	Ursula Grohmann, University of Perugia, Italy Antagonizing IDO-Dependent Tolerogenesis
	Elizabeth M. Jaffee, Johns Hopkins University, USA Metronomic Cyclophosphamide as a Neoadjuvant Therapy in Pancreatic Cancer
7:00 - 8:00 PM	Social Hour w/ Lite Bites	Sweeney Ballroom A-B, Main Level Breakout Rooms
7:30 - 10:00 PM	Poster Session 3 Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom A-B, Main Level Breakout Rooms
Wednesday, February 16
7:00 - 8:00 AM	Breakfast	Sweeney Ballroom A-B, Main Level Breakout Rooms
8:00 - 11:00 AM	Dendritic Cells in situ: Function and Biology Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom F
	Maria Rescigno, European Institute of Oncology, Italy DCs in Intestinal Disease
	Bart N. Lambrecht, Ghent University, Belgium Airway Dendritic Cell Biology
	Speaker to be Announced, Imaging
	Hiroshi Ohno, RIKEN Research Center for Allergy and Immunology, Japan Short Talk: M Cells and Antigen Delivery to DCs in the Gut
	Short Talk(s) to be Chosen from Abstracts,
Following Session is for Tumor Immunology (J8)
8:00 - 11:00 AM	Cancer Vaccines: Prophylaxy or Therapy Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom C-E
	Anna Karolina Palucka, Baylor Institute for Immunology Research, USA DC Vaccine Update
	Giorgio Parmiani, San Raffaele Foundation Scientific Institute, Italy Peptide-Based Vaccine Update
	Vincent G. Brichard, GlaxoSmithKline Biologicals, Belgium Development of the MAGE-A3 ASCI: From Tumor Specificity to Predictive Biomarkers
	Tibor P. Keler, Celldex Therapeutics, Inc., USA DC Targeting in Humans
	Short Talk(s) to be Chosen from Abstracts,
9:00 - 9:20 AM	Coffee Break	Sweeney Ballroom A-B
2:30 - 4:30 PM	Workshop 3: Perspectives on Breaking Tolerance in Cancer Immunotherapy (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom C-F
	* Laurence Zitvogel, Institut Gustave Roussy, France
	Short Talks to be Chosen from Abstracts, ,
4:30 - 5:00 PM	Coffee Available	Sweeney Ballroom A-B
5:00 - 7:00 PM	Translating Immune Responses Toward and Into the Clinic (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom C-F
	Robert A. Seder, NIAID, National Institutes of Health, USA TLRs in Vaccine Development
	Gerold Schuler, University Hospital of Erlangen, Germany DC-Based Gene Immunotherapy in Melanoma
	Peter Kufer†, Micromet AG, Germany Bispecific Single Chain Antibodies for Cancer Therapy
7:00 - 8:00 PM	Closing Keynote Address (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 01/12/2011	Sweeney Ballroom C-F
	Ralph M. Steinman, Rockefeller University, USA In vivo Veritas in Humans
8:00 - 9:00 PM	Social Hour w/ Lite Bites	Sweeney Ballroom A-B
8:00 - 11:00 PM	Entertainment	Sweeney Ballroom A-B
Thursday, February 17
	Departure
*=Session Chair     †=Speaker invited, not yet responded.

Current studies of Dendritic Cells (DCs) have confirmed not only their major role as antigen presenting cells in adaptive immunity but also their important functions in maintaining tolerance and in the initiation of the innate resistance and inflammatory responses. Thus, DCs function as an important bridge between innate resistance and adaptive immunity either through cellular interactions or secretion of pro-inflammatory and immunoregulatory cytokines. The origin and migration pattern of DCs, their cell biological mechanisms of action, their functional diversity, their specializations and activities in specific tissue contexts, as well as their sharing of hematopoietic lineages, functions, and receptors with other phagocytic cell types such as monocytes and macrophages are subjects of intense investigation. Increasingly, the role of dendritic cells in disease pathology and as potential therapeutic targets is being explored both in the laboratory and in the clinic. This is particularly true in human cancer, where both active and passive immunotherapies involving dendritic cells are finally being put to the test in a systematic fashion. In this symposium, each of these aspects of dendritic cell biology and immunological function will be explored in detail, including taking a number of “in depth” looks at functions (such as innate activation mechanisms) that are key to understanding how dendritic cells perform their many remarkable tasks. In addition, this symposium will combine and synergize with a second, jointly organized symposium entitled "Cancer Control by Tumor Suppressors and Immune Effectors", thereby emphasizing emerging concepts concerning the role of the immune response in cancer and cancer therapy.